Risk of breast cancer among users of aspirin and other anti-inflammatory drugs

British Journal of Cancer
L A García Rodríguez, A González-Pérez

Abstract

We conducted a cohort study with a nested case-control analysis to evaluate the effect of anti-inflammatory drugs in breast cancer incidence using the General Practice Research Database. Women taking aspirin and paracetamol for 1 year or longer had an odds ratio (OR) of 0.77 (95 percent confidence interval (95% CI): 0.62,0.95) and 0.76 (95% CI: 0.65,0.88), respectively, compared to nonusers. Daily doses of aspirin (75 mg) and paracetamol (up to 2000 mg) showed the greatest reduced risk. Use of non-aspirin nonsteroidal anti-inflammatory drugs for more than 1 year was not associated with a reduced risk of breast cancer (OR=1.00 (95% CI: 0.84, 1.17), and the corresponding estimate among users with at least 2 years duration was similar. Our findings suggest that aspirin at cardioprophylactic doses as well as paracetamol at analgesic doses is associated with a reduced risk of breast cancer.

References

Dec 15, 1991·The New England Journal of Medicine·M J ThunC W Heath
Mar 1, 1994·Epidemiology·D M Schreinemachers, R B Everson
Jul 17, 1996·Journal of the National Cancer Institute·K M EganG A Colditz
Mar 1, 1996·Epidemiology·R E HarrisW B Farrar
Feb 22, 1997·Lancet·H JickC R Meier
Nov 14, 1997·International Journal of Cancer. Journal International Du Cancer·P K LalaA Orucevic
Jan 24, 1998·Lancet·D W CramerE R Greenberg
Jun 27, 1998·British Journal of Clinical Pharmacology·L A García Rodríguez, S Pérez Gutthann
Aug 11, 1998·Frontiers in Bioscience : a Journal and Virtual Library·S Chen
May 5, 2001·British Journal of Cancer·S A Khuder, A B Mutgi
Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Søren FriisJørgen H Olsen
Feb 21, 2002·Journal of the National Cancer Institute·Michael J ThunCarlo Patrono
Aug 8, 2002·Journal of the National Cancer Institute·Kristin E AndersonAaron R Folsom
Nov 26, 2008·Pharmacoepidemiology and Drug Safety·M M Joffe

❮ Previous
Next ❯

Citations

Aug 15, 2014·Endocrine-related Cancer·V FendrichJ Waldmann
Apr 3, 2008·Cancer Research·Akila N ViswanathanSusan E Hankinson
Oct 9, 2008·Journal of the National Cancer Institute·Louise R Howe, Scott M Lippman
Aug 31, 2011·Cancer Causes & Control : CCC·Jaclyn L F BoscoLynn Rosenberg
Nov 4, 2008·Breast Cancer Research and Treatment·Ya-shuang ZhaoXia Li
Apr 21, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BosettiC La Vecchia
Oct 9, 2008·Journal of the National Cancer Institute·Bahi TakkoucheMahyar Etminan
Jun 7, 2007·Journal of the National Cancer Institute·Shumin M ZhangPaul M Ridker
Aug 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xuehong ZhangSusan E Hankinson
Mar 3, 2017·Scientific Reports·Andrea SetiawanYudi Pawitan
Mar 9, 2018·Cancer Causes & Control : CCC·Tengteng WangMarilie D Gammon
Oct 11, 2014·World Journal of Clinical Oncology·Randall E HarrisZachary M Harris
Feb 22, 2008·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Søren FriisJørgen H Olsen
Jul 15, 2006·Cancer Causes & Control : CCC·Cristina BosettiCarlo La Vecchia
May 10, 2007·European Journal of Epidemiology·Scott Davis, Dana K Mirick
Feb 26, 2008·Breast Cancer Research and Treatment·Anne McTiernanUNKNOWN WHI Investigators
Jan 16, 2008·International Journal of Clinical Practice·A Agrawal, I S Fentiman
Apr 15, 2010·Arthritis Care & Research·Nancy A ShadickI-Min Lee
Jul 16, 2005·Journal of Internal Medicine·D Pereg, M Lishner
Jan 20, 2006·British Journal of Cancer·D MazharJ Waxman
Feb 24, 2006·Current Opinion in Obstetrics & Gynecology·Katherine D Crew, Alfred I Neugut
Feb 10, 2007·International Journal of Cancer. Journal International Du Cancer·Jeanine M GenkingerDominique S Michaud
Jan 16, 2015·Breast Cancer Research and Treatment·María de PedroJavier Llorca
Sep 8, 2011·Breast Cancer Research and Treatment·Ting LuoHong Zheng
Mar 3, 2007·International Journal of Cancer. Journal International Du Cancer·Lisa GallicchioKathy J Helzlsouer
Oct 24, 2007·Pharmacoepidemiology and Drug Safety·Sandra MangiapanePeter Schlattmann
Aug 19, 2011·Veterinary and Comparative Oncology·K Sonzogni-DesautelsM Doré
May 23, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A MacciòG Mantovani
Jun 14, 2014·Oncology Reports·Nadia J Jacobo-HerreraAlejandro Zentella-Dehesa
Apr 10, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Martha L SlatteryRoger R Wolff
May 17, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mary Beth TerryYuyan Liao

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.